Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Colorcon
Mallinckrodt
McKinsey
Express Scripts
Medtronic

Last Updated: November 18, 2019

DrugPatentWatch Database Preview

Details for Patent: 6,559,183

See Plans and Pricing

« Back to Dashboard

Which drugs does patent 6,559,183 protect, and when does it expire?

Patent 6,559,183 protects AMELUZ and is included in one NDA.

This patent has thirteen patent family members in eleven countries.

Summary for Patent: 6,559,183
Title: Nano-emulsion of 5-aminolevulinic acid
Abstract:The present invention relates to a composition comprising a nano-emulsion that contains 5-aminolevulinic acid as well as a carrier in an aqueous phase. This invention also relates to a pharmaceutical preparation containing this composition. The nano-emulsions of this type can be used in photodynamic therapy as well as in the photodiagnostic detection of proliferatives cells.
Inventor(s): Schmid; Hans W. (Zug, CH), Burmeister; Gerd (Oberarth, CH)
Assignee: ASAT AG Applied Science & Technology (Zug, CH)
Application Number:09/831,564
Patent Claim Types:
see list of patent claims
Composition; Compound; Device; Process; Use;

Drugs Protected by US Patent 6,559,183

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Biofrontera AMELUZ aminolevulinic acid hydrochloride GEL;TOPICAL 208081-001 May 10, 2016 RX Yes Yes   Start Trial   Start Trial Y TREATMENT OF ACTINIC KERATOSES BY PHOTODYNAMIC THERAPY   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,559,183

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Germany198 52 245Nov 12, 1998
PCT Information
PCT FiledNovember 12, 1999PCT Application Number:PCT/EP99/08711
PCT Publication Date:May 25, 2000PCT Publication Number: WO00/28971

International Family Members for US Patent 6,559,183

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 260092   Start Trial
Australia 1271000   Start Trial
Australia 758098   Start Trial
Canada 2351620   Start Trial
Germany 19852245   Start Trial
Germany 59908665   Start Trial
European Patent Office 1128812   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Mallinckrodt
Boehringer Ingelheim
McKinsey
Express Scripts
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.